Martin Alexander Leitritz

Learn More
PURPOSE Loteprednol etabonate (LE) is approved by the US FDA in a suspension and ointment form (0.5%) for the treatment of postoperative ocular inflammation. This study examined the gel formulation of LE, an improved, nonsettling formulation with a lower preservative level and a more physiologic pH. PATIENTS AND METHODS This multicenter, double-masked,(More)
BACKGROUND The aim of this study was to compare the long-term outcomes of ab externo trabeculotomy in primary open-angle glaucoma (POAG) and uveitic glaucoma (UG). DESIGN This was a retrospective single-center case series study. PARTICIPANTS Twenty eyes of 17 patients with POAG and 22 eyes of 18 patients with UG were included in this study. PATIENTS(More)
PURPOSE To report the visual and morphological outcomes following intravitreal bevacizumab in neovascular age-related macular degeneration (nAMD) with submacular, predominantly hemorrhagic, lesions. METHODS Retrospective study of patients with a follow-up after 1 year. All eyes with submacular hemorrhages larger than 50% of the total lesion size and(More)
PURPOSE To evaluate a digital high-speed camera combined with digital morphometry software for dynamic measurements of phakic intraocular lens movements to observe kinetic influences, particularly in fast direction changes and at lateral end points. MATERIALS AND METHODS A high-speed camera taking 300 frames per second observed movements of eight(More)
  • 1